Skip to main navigation Skip to search Skip to main content

The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium

  • Parambir S. Dulai
  • , Siddharth Singh
  • , Xiaoqian Jiang
  • , Farhad Peerani
  • , Neeraj Narula
  • , Khadija Chaudrey
  • , Diana Whitehead
  • , David Hudesman
  • , Dana Lukin
  • , Arun Swaminath
  • , Eugenia Shmidt
  • , Shuang Wang
  • , Brigid S. Boland
  • , John T. Chang
  • , Sunanda Kane
  • , Corey A. Siegel
  • , Edward V. Loftus
  • , William J. Sandborn
  • , Bruce E. Sands
  • , Jean Frederic Colombel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science